Latest News

STAT Plus: BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’

WASHINGTON — The sprawling trade association for companies making everything from weed killer to CAR-T cancer therapies, the Biotechnology Innovation Organization, has new leadership. But it’s still not apologizing for the toxic reputation many of its member companies have on Capitol Hill, and in the minds of Americans, more generally.

BIO elected Dr. Jeremy Levin, CEO of Ovid Therapeutics, to be its new board chair in June. It was a planned transition, but one that the group insists will foster more open and frequent communication about the positive role biotech companies play in American life. The group also recently hired a new executive vice president to spearhead its messaging.

Continue to STAT Plus to read the full story…

Source link

Related posts

Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer


EMMAC Life Sciences Limited: £11 million Raised via Successful Private Placing


Study supports that muscle strengthening associated with reduced obesity


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World